Sorrento Therapeutics Inc (NASDAQ:SRNE)

11.36
Delayed Data
As of Mar 30
 -0.93 / -7.57%
Today’s Change
3.10
Today|||52-Week Range
14.30
+12.81%
Year-to-Date
No recent news for Sorrento Therapeutics Inc.

Today’s Trading

Previous close12.29
Today’s open12.30
Day’s range-- - --
Volume463,999
Average volume (3 months)387,537
Market cap$445.0M
Dividend yield--
Data as of 03/30/2015

Growth & Valuation

Earnings growth (last year)-192.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-21.18%
P/E ratioNM
Price/Sales264.85
Price/Book4.24

Competitors

 Today’s
change
Today’s
% change
PRTKParatek Pharmaceutic...-0.35-1.14%
XNPTXenoport Inc+0.09+1.26%
SCLNSciClone Pharmaceuti...+0.27+3.11%
RVNCRevance Therapeutics...+0.59+3.10%
Data as of 03/30/2015

Financials

Next reporting dateJune 3, 2015
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$460.1K
Annual profit (last year)-$21.9M
Net profit margin-4,761.79%

Profile

Sector
Miscellaneous
Industry
Miscellaneous
President, Chief Executive Officer &
Director
Henry H. Ji
Chief Financial &
Accounting Officer
Douglas J. Langston
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account